P1366: SAR442257, A CD38/CD28/CD3 TRISPECIFIC ANTIBODY, POTENTIATES CAR T-CELL ACTIVITY AGAINST LARGE B-CELL LYMPHOMA

• Patrick Reville,
• Enyu Dai,
• Irtiza Sheikh,
• Qing Deng,
• Jared Henderson,
• Cuong Le,
• Estela Rojas,
• Chizitara Okwuchi,
• Ashley Wilson,
• Sydney Parsons,
• Shyanne Lockman,
• Peter Kim,
• Kamlesh Bisht,
• Helgi van de Velde,
• Hongfang Wang,
• Sattva Neelapu,
• Linghua Wang,
• Michael Green

Affiliations

Patrick Reville

1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Enyu Dai

2 University of Texas MD Anderson Cancer Center, Genomic Medicine, Houston, United States

Irtiza Sheikh

3 University of Texas MD Anderson Cancer Center, Pediatrics, Houston, United States

Qing Deng

4 University of Texas MD Anderson Cancer Center, Lymphoma and Myeloma, Houston, United States

Jared Henderson

4 University of Texas MD Anderson Cancer Center, Lymphoma and Myeloma, Houston, United States

Cuong Le

4 University of Texas MD Anderson Cancer Center, Lymphoma and Myeloma, Houston, United States

Estela Rojas

4 University of Texas MD Anderson Cancer Center, Lymphoma and Myeloma, Houston, United States

Chizitara Okwuchi

4 University of Texas MD Anderson Cancer Center, Lymphoma and Myeloma, Houston, United States

Ashley Wilson

4 University of Texas MD Anderson Cancer Center, Lymphoma and Myeloma, Houston, United States

Sydney Parsons

4 University of Texas MD Anderson Cancer Center, Lymphoma and Myeloma, Houston, United States

Shyanne Lockman

4 University of Texas MD Anderson Cancer Center, Lymphoma and Myeloma, Houston, United States

Peter Kim

5 Sanofi, R&D, Cambridge, United States

Kamlesh Bisht

5 Sanofi, R&D, Cambridge, United States

Helgi van de Velde

6 Sanofi, Oncology Development, Belgium

Hongfang Wang

5 Sanofi, R&D, Cambridge, United States

Sattva Neelapu

4 University of Texas MD Anderson Cancer Center, Lymphoma and Myeloma, Houston, United States

Linghua Wang

2 University of Texas MD Anderson Cancer Center, Genomic Medicine, Houston, United States

Michael Green

4 University of Texas MD Anderson Cancer Center, Lymphoma and Myeloma, Houston, United States